Liven Pharma Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-705.64	-584.46	41.74	-12.33	-14.29	-14.63
Depreciation & Amortization	31.7	27.17	24.87	13.1	14.56	16.08
Other Amortization	328.27	328.27	0.69	-	-	-
Provision & Write-off of Bad Debts	121.57	116.87	-	-	-	-
Other Operating Activities	130.58	92.58	1.15	-2.9	-3.22	-3.55
Change in Accounts Receivable	-19.98	-21.52	-42.29	-	-	-
Change in Inventory	-3.4	0.46	-11.82	-	-	-
Change in Accounts Payable	54.59	39.43	0.21	-	-0.07	-4.16
Change in Other Net Operating Assets	-0.5	-0.52	-0.75	-0.14	0.76	-0.52
Operating Cash Flow	12.69	-1.72	13.8	-2.27	-2.26	-6.79
Capital Expenditures	-37.68	-22.84	-	-	-	-
Sale (Purchase) of Intangibles	-9.41	-10	-	-	-	-
Investing Cash Flow	-239.61	-32.84	-	-	-	-
Short-Term Debt Issued	-	168.72	11.34	2.27	2.24	6.79
Long-Term Debt Issued	-	6.68	1.36	-	-	-
Total Debt Issued	215.68	175.4	12.7	2.27	2.24	6.79
Short-Term Debt Repaid	-	-156.14	-	-	-	-
Long-Term Debt Repaid	-	-1.8	-3.54	-	-	-
Total Debt Repaid	-7.88	-157.94	-3.54	-	-	-
Net Debt Issued (Repaid)	207.8	17.46	9.16	2.27	2.24	6.79
Financing Cash Flow	207.8	17.46	9.16	2.27	2.24	6.79
Miscellaneous Cash Flow Adjustments	-17.32	0.03	-	-	-	-
Net Cash Flow	-36.44	-17.07	22.96	0	-0.02	-0.01
Free Cash Flow	-24.98	-24.56	13.8	-2.27	-2.26	-6.79
Free Cash Flow Margin	-29.53%	-19.30%	5.63%	-	-	-
Free Cash Flow Per Share	-0.27	-0.35	345.08	-0.19	-0.19	-0.56
Cash Interest Paid	1.8	0.47	0.1	-	-	-
Levered Free Cash Flow	148.64	151.56	-163.82	3.45	4.31	0.03
Unlevered Free Cash Flow	149.91	152.02	-163.81	3.45	4.31	0.03
Change in Working Capital	30.71	17.84	-54.65	-0.14	0.7	-4.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.